Diabetes management in CKD, SGLT2 inhibitors, GLP-1 receptor agonists, finerenone, lipid management and glycaemic targets.

Use these pages as guideline-derived source summaries. For rapid bedside or outpatient decision-making, start with the relevant Clinical pathway and use this section to check the underlying recommendations.